Appreciating the User's Perspective: Listening to the “Methadonians”

Montagne, Michael

doi:10.1081/ja-120002814

Cited by 24 publications

(19 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As others have noted, there is a vast difference between the perceptions and experiences of illicit drug users and those who design and provide drug treatment services. 36 Without an understanding of the users' perspective there is great risk of services being mistargeted for those who require them, and of the evaluation of those services missing, or misrepresenting, their value to clients. Our findings also point to a need for careful training of health care workers who will engage with this population to prepare them for the concerns and possible previous experiences of their clients.…”

Section: Discussionmentioning

confidence: 99%

Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment

Brener¹,

Treloar²

2009

Aust. Health Review

View full text Add to dashboard Cite

To assess whether HCV-positive clients perceive that alcohol and other drug (AOD) staff discriminate against them, this study compared the treatment experiences of 120 HCV-positive clients with those of 120 HCV-negative clients attending the same AOD treatment facility. Despite the overall findings of favourable attitudes of HCV-positive clients toward their health care workers, these attitudes were less positive than those of their HCV-negative counterparts. Clients with HCV also rated their interpersonal treatment by their health care workers less favourably. These findings suggest that HCV-positive clients' attitudes towards their health care workers and their experiences of differential treatment by these health care workers might be a barrier to HCV treatment uptake in

show abstract

Section: Discussionmentioning

confidence: 99%

Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment

Brener¹,

Treloar²

2009

Aust. Health Review

View full text Add to dashboard Cite

show abstract

“…Drug users are seldom seen as important sources of information and their personal perspectives about substance abuse treatment and life in general are not widely reported in the literature (Drumm et al, 2003;Fischer, Rehm, & Kim, 2001;Kolind, 2007;Montagne, 2002), even though such studies may present an alternative perspective on these issues (Brun & Rapp, 2001;Vanderplasschen & De Maeyer, 2007). Yet, information on the impact of health problems and their treatment on the daily life of individuals' suffering from chronic illnesses is often more revealing than objective outcome indicators regarding individuals' functioning or clinical recovery (Wiklund, 2004).…”

Section: Introductionmentioning

confidence: 99%

Treatment satisfaction and quality of support in outpatient substitution treatment: opiate users’ experiences and perspectives

Vanderplasschen¹,

Naert²,

Laenen

et al. 2014

Drugs: Education, Prevention and Policy

View full text Add to dashboard Cite

Aims: Patient-reported outcomes have become an important source of information to guide service provision. Although opiate substitution treatment (OST) is an evidence-based and widely available intervention for opiate dependent individuals, evaluation studies have primarily focused on objective outcome indicators rather than on clients' perspectives and personal experiences. This study aims to assess opiate users' satisfaction with various aspects of substitution treatment and their subjective experiences and expectations regarding the provision of psychosocial support. Methods: The study sample consisted of 77 opiatedependent individuals who had been involved in OST for at least three months in some cities in Belgium. Qualitative interviews were used to explore clients' subjective experiences, in addition to some quantitative measures. Findings: About half of the respondents recently received some form of psychosocial support and they were generally satisfied about these services. However, the number of persons who wanted psychosocial support clearly outnumbered those actually receiving these services. Respondents stressed the importance of building trusting relationships with OST staff. Also, the need for more flexible and individualised support was emphasised. Conclusions: Compared with other stakeholders' perspectives or traditional outcome indicators, service users' subjective experiences shed an alternative light on the impact of opiate dependence and OST on individuals' daily lives. This information should be incorporated in individual treatment planning and when designing and evaluating OST services.

show abstract

“…However, there is an increasing recognition that these constitute essential measures of MAT quality (Tiffany et al, 2012;Trujols et al, 2011;Uchtenhagen, 2015). Few studies have investigated subjective views of MAT episodes (Montagne, 2002;Stancliff, 2002), and, if so, mostly addressed patient satisfaction (Kelly et al, 2010;Marchand et al, 2011;Trujols et al, 2012). Fewer studies still have investigated the views of treatment providers (Becker and Fiellin, 2006).…”

Section: Introductionmentioning

confidence: 99%

Evaluation of medication-assisted treatment of opioid dependence—The physicians’ perspective

Vogel

Nordt

Dürsteler

et al. 2016

Drug and Alcohol Dependence

View full text Add to dashboard Cite

BACKGROUND: There is controversy about which outcome parameters should be employed to assess substance use treatment. Subjective measures of medication-assisted treatment (MAT) of opioid dependence are increasingly important. However, while patients' perspectives have been examined, the caregivers' views remain largely unknown. Here, we explore how physicians evaluate MAT, and which predictors are most relevant. METHODS: We conducted a retrospective cohort study of all MAT episodes with oral opioid agonists in the canton of Zurich between 1998 and 2013 using a case register. Termination forms of the register include a physician-completed assessment on the course of the treatment episode. Mixed model analysis was applied to determine relevant predictors. RESULTS: The analysis was based on 17,234 episodes from 7432 patients. Mean global assessment of the course of MAT was 'moderate'. The most important predictors for treatment evaluation by physicians were treatment break off as reason for termination (p<0.0001), psychological improvement throughout treatment (p<0.0001), wish for abstinence from the substitute (p<0.0001), social integration index at termination (p<0.0001), and social (p<0.0001) as well as medical (p<0.0001) improvement. The negative association of treatment break off with MAT assessment was more pronounced in semi-rural than urban areas (p<0.0001). CONCLUSION: Predictors relating to the well-being and functioning of the patient as well as the reasons underlying treatment termination appear to be more important for the treating physician's evaluation of medication-assisted treatment episodes than on-going substance use. Coming off the opioid medication plays a central role, independent of ongoing illicit substance use. Predictors relating to the well-being and functioning of the patient as well as the reasons underlying treatment termination appear to be more important for the treating physician's evaluation of medication-assisted treatment episodes than on-going substance use. Coming off the opioid medication plays a central role, independent of ongoing illicit substance use.

show abstract

Appreciating the User's Perspective: Listening to the “Methadonians”

Cited by 24 publications

References 6 publications

Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment

Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: implications for hepatitis C treatment

Treatment satisfaction and quality of support in outpatient substitution treatment: opiate users’ experiences and perspectives

Evaluation of medication-assisted treatment of opioid dependence—The physicians’ perspective

Contact Info

Product

Resources

About